[Federal Register Volume 88, Number 73 (Monday, April 17, 2023)]
[Notices]
[Page 23427]
From the Federal Register Online via the Government Publishing Office [www.gpo.gov]
[FR Doc No: 2023-07992]


-----------------------------------------------------------------------

DEPARTMENT OF HEALTH AND HUMAN SERVICES

Centers for Disease Control and Prevention


Solicitation of Nominations for Appointment to the Advisory 
Council for the Elimination of Tuberculosis

AGENCY: Centers for Disease Control and Prevention (CDC), Department of 
Health and Human Services (HHS).

ACTION: Notice.

-----------------------------------------------------------------------

SUMMARY: The Centers for Disease Control and Prevention (CDC), within 
the Department of Health and Human Services (HHS), is seeking 
nominations for membership on the Advisory Council for the Elimination 
of Tuberculosis (ACET). ACET consists of 10 experts including the Chair 
in fields associated with public health, epidemiology, immunology, 
infectious diseases, pulmonary disease, pediatrics, tuberculosis, 
microbiology, and preventive health care delivery.

DATES: Nominations for membership on ACET must be received no later 
than August 31, 2023. Packages received after this time will not be 
considered for the current membership cycle.

ADDRESSES: All nominations should be emailed to [email protected] 
with the subject line ``ACET 2024 Nomination'' or faxed to (404) 639-
8600.

FOR FURTHER INFORMATION CONTACT: Marah Condit, MS, Committee Management 
Lead, Office of Policy, Planning, and Partnerships, National Center for 
HIV, Viral Hepatitis, STD, and TB Prevention, Centers for Disease 
Control and Prevention, 1600 Clifton Road NE, Mailstop US8-6, Atlanta, 
Georgia 30329-4027. Telephone: (404) 639-3423; Email: [email protected].

SUPPLEMENTARY INFORMATION: The Advisory Council for the Elimination of 
Tuberculosis (ACET) provides advice and recommendations regarding the 
elimination of tuberculosis (TB) to the Secretary, Department of Health 
and Human Services (HHS); the Assistant Secretary for Health, HHS; and 
the Director, Centers for Disease Control and Prevention (CDC). ACET 
(a) makes recommendations on policies, strategies, objectives, and 
priorities; (b) addresses development and application of new 
technologies; (c) provides guidance and review of CDC's TB prevention 
research portfolio and program priorities; and (d) reviews the extent 
to which progress has been made toward eliminating TB.
    Nominations are sought for persons who have expertise and 
qualifications necessary to contribute to the accomplishment of the 
objectives of ACET. Nominees will be selected on the basis of their 
expertise in public health, epidemiology, immunology, infectious 
diseases, pulmonary disease, pediatrics, tuberculosis, microbiology, or 
preventive health care delivery. Federal employees will not be 
considered for membership. Members may be invited to serve for up to 
four-year terms. Selection of members is based on candidates' 
qualifications to contribute to the accomplishment of ACET objectives.
    HHS policy stipulates that committee membership be balanced in 
terms of points of view represented and the committee's function. 
Appointments shall be made without discrimination on the basis of age, 
race, ethnicity, gender, sexual orientation, gender identity, HIV 
status, disability, and cultural, religious, or socioeconomic status. 
Nominees must be U.S. citizens and cannot be full-time employees of the 
U.S. Government. Current participation on federal workgroups or prior 
experience serving on a federal advisory committee does not disqualify 
a candidate; however, HHS policy is to avoid excessive individual 
service on advisory committees and multiple committee memberships. 
Committee members are Special Government Employees, requiring the 
filing of financial disclosure reports at the beginning of and annually 
during their terms. CDC reviews potential candidates for ACET 
membership each year and provides a slate of nominees for consideration 
to the Secretary of HHS for final selection. HHS notifies selected 
candidates of their appointment near the start of the term in July 
2024, or as soon as the HHS selection process is completed. Note that 
the need for different expertise varies from year to year and a 
candidate who is not selected in one year may be reconsidered in a 
subsequent year. Candidates should submit the following items:
    [ssquf] Current curriculum vitae, including complete contact 
information (telephone numbers, mailing address, and email address).
    [ssquf] At least one letter of recommendation from person(s) not 
employed by HHS. Candidates may submit letter(s) from current HHS 
employees if they wish, but at least one letter must be submitted by a 
person not employed by an HHS agency (i.e., CDC, National Institutes of 
Health, Food and Drug Administration, etc.).
    Nominations may be submitted by the candidate or by the person/
organization recommending the candidate.
    The Director, Strategic Business Initiatives Unit, Office of the 
Chief Operating Officer, Centers for Disease Control and Prevention, 
has been delegated the authority to sign Federal Register notices 
pertaining to announcements of meetings and other committee management 
activities, for both the Centers for Disease Control and Prevention and 
the Agency for Toxic Substances and Disease Registry.

Kalwant Smagh,
Director, Strategic Business Initiatives Unit, Office of the Chief 
Operating Officer, Centers for Disease Control and Prevention.
[FR Doc. 2023-07992 Filed 4-14-23; 8:45 am]
BILLING CODE 4163-18-P